FIGURE 7:
ZO-3–cyclin D1 interaction regulates cell proliferation in epithelial cells by promoting S-phase transition. (A) Western blot analysis of SKCO-15 cell lysates treated with control siRNA (Control) or ZO-3 directed siRNA. (B) Growth curve showing cell number over 3 d posttransfection with control siRNA (Control, ◊) or ZO-3 directed siRNA (▪) (*p < 0.001, n = 4). (C) Propidium iodide–stained SKCO-15 cells, treated with either scrambled siRNA (Control, black) or ZO-3–directed siRNA (red) were assayed for cell-cycle status by flow cytometry (n = 2). (D) Confluent SKCO-15 cell monolayers (control) were scratch wounded to stimulate cell proliferation (dotted line marks wound edge; mitotic cells are marked with white arrows). Scale bar = 20 μm. (E) Scratch-wounded monolayers show increased cyclin D1 as well as increased phospho-Thr-286–cyclin D1 when compared with confluent cultures (control). (F) Western blot showing enhanced ZO-3 coimmunoprecipitation with cyclin D1 from lysates of scratch-wounded cells. (G) Hypothetical model whereby ZO-3 acts to sequester cyclin D1 at TJs during mitosis. This prevents cyclin D1 degradation during M-phase and promotes S-phase transition. Without ZO-3, cyclin D1 is degraded during M-phase, delaying cells in G1.